No Data
No Data
Zhejiang Jianfeng's Pharmaceutical Arm Gets Nod to Market Diquafosol Sodium Eye Drops
Zhejiang Jianfeng Group's (SHSE:600668) Anemic Earnings Might Be Worse Than You Think
Zhejiang Jianfeng's Pharmaceutical Unit Gets Nod to Register Sodium Hyaluronate Eye Drops
Zhejiang Jianfeng Group Co., Ltd. (SHSE:600668) Investors Are Less Pessimistic Than Expected
Shareholders 26% Loss in Zhejiang Jianfeng Group (SHSE:600668) Partly Attributable to the Company's Decline in Earnings Over Past Year
Zhejiang Jianfeng Group Receives Drug Registration for Sodium Hyaluronate Eye Drops